1. Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer. Issue 6 (5th June 2017) Authors: Adiwijaya, BS; Kim, J; Lang, I; Csõszi, T; Cubillo, A; Chen, J‐S; Wong, M; Park, JO; Kim, JS; Rau, KM; Melichar, B; Gallego, JB; Fitzgerald, J; Belanger, B; Molnar, I; Ma, WW Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 6(2017) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-207Clinical and molecular characteristics of biliary tract carcinoma using next-generation sequencing. (2nd July 2019) Authors: Ceniceros, L; Álvarez, R; Muñoz, C; Sanz-García, E; Ugidos, L; Rodriguez-Pascual, J; Hernandez, S; Gomez, P; Garcia-Rico, E; Cubillo, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-100Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress. (20th June 2018) Authors: Cheng, A; Abou-Alfa, G; Ren, Z; Assenat, E; Cubillo, A; Pluntke, S; Rimassa, L; Ross, P; Wyrwicz, L; Hou, J; Li, C; Wu, J; Ducreux, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LBA29CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer. (23rd October 2018) Authors: Ko, A H; Cubillo, A; Kundranda, M; Zafar, S F; Meiri, E; Bendell, J; Alguel, H; Rivera Herrero, F; Ahn, E; Watkins, D; Pelzer, U; Charu, V; Downing, W; Wang, B; Kuesters, G; Pipas, J M; Santillana, S L; Askoxylakis, V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗